TEV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Teva Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 30 EUR 8.3% Market Closed

Market Cap: €21B

T	Teva Pharmaceutical Industries Ltd SWB:TEV	IL
	Iberdrola SA MAD:IBE	ES
U	United Therapeutics Corp F:UTH	US

Profitability Summary

Teva Pharmaceutical Industries Ltd's profitability score is 54/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Strong 3Y Average Gross Margin

51%

Gross Margin is Increasing

49% > 53%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

22%

Declining Operating Margin

21% > 19%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-15% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

8% > 8%

Low ROE

10%

Negative 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

9% > 10%

View All

Hide

Collapse

54 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.